Management of Patients before and after COVID-19

Cancer patients are at high risk for severe cases of COVID-19. There is no report in the literature reflecting the perspectives of gynaecological cancer patients facing both COVID thread and also facing such modifications in their treatment and follow-up, in such a short time.

ENGAGe member societies have conducted a study in different European countries to evaluate the effects of COVID with a patient perspective for the first time in the literature.

In this study, it was aimed to evaluate the impression of COVID pandemic over the gynaecological cancer patients and the patients’ attitudes and experiences upon modifications of their cancer care and also to assess the depression and anxiety scores using HADS (Hospital Anciety and Depression Scale).

ESGO and ENGOT has also made a parallel survey reflecting the changes of medical care across Europe for gyn cancers.

The webinar will present the initial results so attendees will have a chance to compare and discuss bot the doctors and patients perspectives.

The presentations will be followed by a panel of ESGO experts with answering the questions of doctors and patients for surgery, medical oncology and radiaiton oncology, to help their communication in the next months' re-organisation phase.